Sort
261,768 grants matching “gene therapy”
WU-MDACC Inter-Institutional Molecular Imaging Center
$1,336,045Samuel Achilefu · Washington University · P50 · FY2013 · CA
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer
$1,336,035Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
SEARCH FOR SELECTIVE THERAPY OF CML
$1,335,531Bayard D Clarkson · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
PET, APOE & the Preclinical Course of Alzheimer's Disease
$1,335,485Eric M Reiman · Banner Alzheimer'S Institute · R01 · FY2009 · AG
Pharmacogenomics of Anti-platelet Agents for CVD Prevent
$1,335,443University Of Maryland Baltimore · U01 · FY2005 · GM
GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS
$1,335,441Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2000 · HL
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
$1,335,301Zihai Li · Medical University Of South Carolina · P01 · FY2017 · CA
Regenerative Scaffold Technologies for CNS and Diabetes
$1,335,217Northwestern University · R01 · FY2004 · EB
Genetic Approaches To Understanding Organ Development and Function
$1,335,092Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Physiology, Psychology, and Genetics of Obesity
$1,334,791Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Establishing a Mutant Mouse Regional Resource Center at The Jackson Laboratory
$1,334,275Leah Rae B Donahue · Jackson Laboratory · U42 · FY2011 · RR
Establishing a Mutant Mouse Regional Resource Center at The Jackson Laboratory
$1,334,274Leah Rae B Donahue · Jackson Laboratory · U42 · FY2012 · OD
Mass Spectrometry Quantitation
$1,334,144Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells
$1,334,000Leslie Michels Thompson · University Of California-Irvine · U54 · FY2015 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells
$1,334,000Leslie Michels Thompson · University Of California-Irvine · U54 · FY2016 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells
$1,334,000Leslie Michels Thompson · University Of California-Irvine · U54 · FY2018 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells
$1,334,000Leslie Michels Thompson · University Of California-Irvine · U54 · FY2014 · NS
Transcriptional regulation of inflammatory and autoimmune responses
$1,333,998Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
$1,333,998Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of iPS Cells for Treatment of Hemoglobinopathies
$1,333,992Yuet W Kan · University Of California, San Francisco · P01 · FY2011 · DK
PREVENTABLE Frailty Ancillary Study
$1,333,801Ariela R Orkaby · Boston Va Research Institute, Inc. · R01 · FY2024 · AG
Somatic Mutations and Their Etiological Determinants for Breast Cancer in African American Women
$1,333,797Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Brewing anti-toxin drugs using probiotic yeast
$1,333,682Nathan C. Crook · North Carolina State University Raleigh · DP2 · FY2023 · AT
Primate Core
$1,333,524Hans-Peter Kiem · University Of Southern California · U19 · FY2023 · HL
Biological mechanisms involved with PDT in the treatment of MPM
$1,333,497Eli J Glatstein · University Of Pennsylvania · P01 · FY2017 · CA